PRECIGEN, INC. - Common Stock (PGEN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
PGEN on Nasdaq
Shares outstanding
332,525,463
Price per share
$4.18
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
111,297,177
Total reported value
$366,220,521
% of total 13F portfolios
0%
Share change
+26,528,533
Value change
+$89,540,549
Number of holders
165
Price from insider filings
$4.18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PRECIGEN, INC. - Common Stock (PGEN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Patient Capital Management, LLC 14% $148,785,193 45,223,463 Patient Capital Management, LLC 31 Dec 2024
Miller William H III 9.2% $154,936,259 34,051,925 William H. Miller III Living Trust dated April 17, 2017 26 Jun 2025

As of 30 Sep 2025, 165 institutional investors reported holding 111,297,177 shares of PRECIGEN, INC. - Common Stock (PGEN). This represents 33% of the company’s total 332,525,463 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PRECIGEN, INC. - Common Stock (PGEN) together control 30% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Patient Capital Management, LLC 8% 26,460,848 +63% 3.5% $87,056,189
TANG CAPITAL MANAGEMENT LLC 3.7% 12,400,000 1.6% $40,796,000
BlackRock, Inc. 3.7% 12,149,955 +9% 0% $39,973,352
VANGUARD GROUP INC 2.7% 8,942,285 -1.4% 0% $29,420,118
STATE STREET CORP 1.4% 4,489,827 +48% 0% $14,771,531
GEODE CAPITAL MANAGEMENT, LLC 1.2% 3,848,738 +2.7% 0% $12,665,203
IRIDIAN ASSET MANAGEMENT LLC/CT 1.1% 3,666,946 -14% 4.7% $12,064,252
Point72 Asset Management, L.P. 0.82% 2,741,066 0.02% $9,018,107
Occam Crest Management LP 0.81% 2,697,400 0% 6% $8,874,446
CITADEL ADVISORS LLC 0.81% 2,695,831 +756% 0.01% $8,869,284
BANK OF AMERICA CORP /DE/ 0.75% 2,505,992 +201% 0% $8,244,713
Parkman Healthcare Partners LLC 0.63% 2,101,715 +36% 0.76% $6,914,642
Driehaus Capital Management LLC 0.61% 2,042,510 0.05% $6,719,858
MORGAN STANLEY 0.6% 1,981,643 -2.9% 0% $6,519,606
NORTHERN TRUST CORP 0.41% 1,375,964 -2.2% 0% $4,526,922
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.38% 1,259,913 -0.85% 0% $4,145,114
Diametric Capital, LP 0.29% 974,228 +191% 1.2% $3,205,210
Schonfeld Strategic Advisors LLC 0.26% 856,593 -40% 0.02% $2,818,188
Boxer Capital Management, LLC 0.26% 850,000 0.89% $2,796,500
ADAGE CAPITAL PARTNERS GP, L.L.C. 0.25% 846,000 -92% 0% $2,783,340
Nuveen, LLC 0.24% 798,807 +61% 0% $2,628,075
Corient Private Wealth LLC 0.24% 797,571 +12% 0% $2,624,009
MILLENNIUM MANAGEMENT LLC 0.23% 779,558 +227% 0% $2,564,746
JPMORGAN CHASE & CO 0.23% 760,395 -2.4% 0% $2,501,699
GOLDMAN SACHS GROUP INC 0.22% 733,487 +45% 0% $2,413,172

Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 53,223 $222,119 +$66,607 $4.18 6
2025 Q3 111,297,177 $366,220,521 +$89,540,549 $3.29 165
2025 Q2 82,070,744 $116,553,437 +$2,653,090 $1.42 146
2025 Q1 80,161,429 $119,337,253 +$7,804,799 $1.49 137
2024 Q4 75,787,342 $84,752,627 +$1,018,038 $1.12 130
2024 Q3 74,934,960 $70,966,781 +$13,973,301 $0.95 123
2024 Q2 60,722,436 $95,930,395 -$1,354,697 $1.58 130
2024 Q1 61,605,921 $89,315,893 -$1,244,521 $1.45 127
2023 Q4 62,597,104 $83,879,140 +$2,482,228 $1.34 136
2023 Q3 60,552,257 $85,976,957 +$4,927,378 $1.42 135
2023 Q2 57,391,361 $65,981,492 -$3,631,686 $1.15 137
2023 Q1 61,459,047 $65,137,179 +$19,788,601 $1.06 155
2022 Q4 42,284,714 $64,263,385 -$330,510 $1.52 157
2022 Q3 125,018,911 $265,021,859 -$18,455,826 $2.12 151
2022 Q2 135,952,580 $182,176,824 -$10,848,844 $1.34 154
2022 Q1 143,469,817 $302,712,530 +$212,819 $2.11 159
2021 Q4 142,860,197 $529,867,886 +$12,686,695 $3.71 157
2021 Q3 138,272,261 $690,254,065 -$19,066,872 $4.99 162
2021 Q2 142,052,644 $926,165,482 -$505,170 $6.52 142
2021 Q1 142,033,611 $978,581,859 +$140,930,422 $6.89 154
2020 Q4 121,129,113 $1,235,480,007 -$19,579,424 $10.20 142
2020 Q3 123,718,445 $433,031,361 +$6,466,151 $3.50 145
2020 Q2 121,163,398 $604,513,971 -$28,168,416 $4.99 134
2020 Q1 129,153,759 $439,106,078 +$437,977,926 $3.40 134
2019 Q4 227,607 $1,148,000 +$636,000 $5.48 4
2019 Q3 42,862 $279,000 $6.51 1
2019 Q2 42,862 $279,000 $6.51 1
2019 Q1 42,862 $279,000 $6.51 1
2016 Q2 0 $0 -$12,709 $4.18 0
2016 Q1 375 $12,709 $33.89 1